During the past decade, Vidant Oncology-Richlands conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 3 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 3 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vidant Oncology-Richlands" #1 sponsor was "National Cancer Institute (NCI)" with 28 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored, "SWOG Cancer Research Network" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vidant Oncology-Richlands" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Janssen, LP" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Vidant Oncology-Richlands" are "Stage IV Lung Cancer AJCC v8" (5 trials), "Lung Non-Squamous Non-Small Cell Carcinoma" (3 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials), "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials) and "Stage IIIA Breast Cancer" (3 trials). Many other conditions were trialed in "Vidant Oncology-Richlands" in a lesser frequency.

Most popular intervention types in "Vidant Oncology-Richlands" are "Drug" (38 trials), "Other" (28 trials), "Biological" (25 trials), "Procedure" (23 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (17 trials), "Computed Tomography" (17 trials), "Quality-of-Life Assessment" (16 trials), "Nivolumab" (10 trials) and "Questionnaire Administration" (10 trials). Other intervention names were less common.

The vast majority of trials in "Vidant Oncology-Richlands" are 43 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Vidant Oncology-Richlands". undefined are not yet recruiting, 20 are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Vidant Oncology-Richlands, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vidant Oncology-Richlands, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".